Best Practices for Chronic Pain Fellows During the COVID-19 Pandemic
Recommendations for addressing mental health among pain management fellows during the COVID-19 pandemic.
Pain Information Center
FDA Requires Labeling Changes for Opioids to Include Information About Naloxone
The FDA has announced that it is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder to include new recommendations about naloxone to the prescribing information.
Clinical Outcomes Associated With Ibuprofen Use During COVID-19
A team of investigators assessed clinical outcomes among patients with COVID-19 receiving ibuprofen for fever reduction.
Role of Allopregnanolone in Menstrually Related and Postmenopausal Migraine
Serum allopregnanolone levels are lower in women with either menstrually related or postmenopausal migraine compared with women without headache.
Higher Rates of Pain, Bleeding Found With Essure Birth Control Device
The permanent birth control device Essure is associated with higher rates of chronic lower abdominal or pelvic pain and abnormal uterine bleeding compared with tubal ligation.
A Case of Unremitting Back Pain Following Kidney Stones
Right-sided flank pain has been present for several months and occurs when standing, bending, and lifting—pain only improves when laying down.
Opioid Use Common Among Patients With Migraine
Approximately one-third of patients with migraine reported using opioids to treat their symptoms, a practice that contrasts with current guidelines.
Galcanezumab Linked to Improved Work Productivity in Patients With Migraine
Galcanezumab was found to significantly improve work productivity and reduce interictal burden in patients with treatment-resistant migraine, according to results from the phase 3 CONQUER study.
Exploring the Link Between Pediatric Migraine & Sleep Disorders
The bidirectional relationship between migraine and sleep disorders are examined in this article.
Positive Outcomes Reported With Novel Intranasal DHE for Migraine
Positive results were announced from the phase 3 STOP-301 study evaluating INP104 (intranasal dihydroergotamine mesylate; Impel NeuroPharma) for the treatment of acute migraine in adults.
Changes in Brain Function, Amygdalar Connectivity Drive Preventative Effect of CBT on Migraine
The investigators observed greater brain activations in the frontal regions associated with cognitive regulation of pain after CBT.
Repetitive Multiple Cranial Nerve Blocks Offer Effective Prevention for Chronic Migraine
Repetitive multiple cranial nerve blocks may offer a clinically meaningful benefit as a preventative measure in patients with chronic migraine.
Sensory Function Compared Among Patients With Cluster, Migraine, and Tension-Type Headache
Researchers evaluated sensory function in the trigeminocervical region in patients with cluster headache, migraine headache, and tension-type headache.
Menstrual Migraine: Revisiting the Relationship Between Hormonal Events and Migraine
A narrative review summarizes recent data on the pathophysiology, epidemiology, and burden of disease and treatment of menstrual migraine.
Youths With Status Migrainosus: Distinct Subgroup With Poor Short-Term Prognosis
Youth with a history of status migranosus are more likely to experience an increase of >4 headache days per month during a follow-up evaluation.
Novel Class of Preventive Treatments for Migraine
Anti-calcitonin gene-related peptide monoclonal antibodies are the first approved pharmacologic treatments developed explicitly for the prevention of migraine.
Yoga With Medical Care Better for Episodic Migraines
Yoga plus medical care is better than medical therapy alone for the treatment of episodic migraines.
Study Characterizes Somatotopically Specific Differences in Pain Modulation in Interictal Migraine Phase
Study findings suggest that pain modulation may be impaired in patients with migraine in the headache-free interval, despite an unaffected sensory profile.
FDA Clears Hand-Held Vagus Nerve Stimulator for Migraine Prevention
The FDA has approved an expanded indication for the gammaCore device to include prevention of migraine.
Prophylactic Manual Acupuncture Reduces Migraine Days
Undergoing 20 sessions of manual acupuncture is superior to sham acupuncture and usual care for prophylactic treatment in migraine.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Pain Information Center
